Published in Clin Nephrol on April 01, 1993
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol (2009) 2.03
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma. Nat Rev Nephrol (2009) 1.05
Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria. Rheumatol Int (2006) 0.80
Recent clinical trials in lupus nephritis. Rheum Dis Clin North Am (2014) 0.78
Presentation and outcome of paediatric membranous non-proliferative lupus nephritis. Pediatr Nephrol (2014) 0.76
25-year-old man with flank pain, hematuria, and proteinuria. Mayo Clin Proc (2009) 0.75
Chapter 12: Lupus nephritis. Kidney Int Suppl (2011) (2012) 0.75
Overview of pathophysiology and treatment of human lupus nephritis. Curr Opin Rheumatol (2016) 0.75
Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. Clin Rheumatol (2016) 0.75
Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study. Medicine (Baltimore) (2017) 0.75
Clinical presentation and outcomes of childhood-onset membranous lupus nephritis. Pediatr Nephrol (2017) 0.75
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet (1999) 3.51
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26
Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int (1997) 2.17
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86
A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med (1992) 1.81
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74
Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int (2001) 1.64
Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int (2007) 1.64
Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant (1995) 1.57
"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int (1996) 1.49
High prevalence of silent gallstone disease in dialysis patients. Nephron (1994) 1.45
Values of the parameter immature reticulocyte fraction in elite athletes. Clin Lab Haematol (2004) 1.42
Gitelman syndrome: pathophysiological and clinical aspects. QJM (2010) 1.39
Microscopic hematuria diagnosis and management. Nephron (1996) 1.39
Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int (1995) 1.39
Regulation of base balance in bicarbonate hemofiltration. Int J Artif Organs (1994) 1.38
How to manage the dialysis patient with chronic viral hepatitis who is considered for renal transplantation. Nephrol Dial Transplant (1996) 1.38
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. J Hypertens (2000) 1.36
Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int (1995) 1.36
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32
A second genetic locus for autosomal dominant polycystic kidney disease. Lancet (1988) 1.29
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res (2009) 1.27
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J (Clin Res Ed) (1987) 1.23
Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int (1995) 1.16
Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res (2000) 1.15
Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med (1986) 1.15
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis (2001) 1.15
Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int (2001) 1.15
The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol (1991) 1.13
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis (2001) 1.13
Renal replacement therapy in the elderly. Q J Med (1989) 1.13
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant (1995) 1.11
Heart rate control in hypertensive patients treated by captopril. Br J Clin Pharmacol (1982) 1.10
Histological evidence of hepatitis-B-virus infection with negative serology in children with acute leukaemia who develop chronic liver disease. Lancet (1982) 1.09
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol (1989) 1.07
Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis (1999) 1.07
Renovascular disease in diabetes mellitus: treatment by percutaneous transluminal renal angioplasty. Nephrol Dial Transplant (1998) 1.07
A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation. Transplantation (1991) 1.07
Cutaneous abnormalities in uremic patients. Nephron (1985) 1.06
Factor VIII and chronic renal failure. Br Med J (1977) 1.06
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet (1996) 1.06
Immunohistochemical staining on hydroxyethyl-methacrylate-embedded tissues. J Histochem Cytochem (1983) 1.05
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04
Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet (1983) 1.04
Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol (1987) 1.02
Acquired dysfunction due to the circulation of "exhausted" platelets. Am J Med (1980) 1.02
Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients. Q J Med (1981) 1.02
Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int (1983) 1.00
ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant (1994) 1.00
Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation (2001) 0.99
Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study. Transplantation (1997) 0.99
Invited review: Dairy intake and bone health: a viewpoint from the state of the art. J Dairy Sci (2011) 0.99
Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis. Nephron (1983) 0.97
EDTA-dependent pseudothrombocytopaenia: a 12-month epidemiological study. Scand J Clin Lab Invest (1988) 0.97
Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference. Clin Chem Lab Med (2000) 0.97
Hepatorenal syndrome. New perspectives in pathogenesis and treatment. Arch Intern Med (1993) 0.96
Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol (1987) 0.95
Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J (Clin Res Ed) (1985) 0.95
Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet (1987) 0.95
Uremic pruritus: a review. Nephron (1992) 0.94
Association of pseudothrombocytopenia and pseudoleukopenia: evidence for different pathogenic mechanisms. Scand J Clin Lab Invest (1994) 0.94
Lymphocyte subpopulations in minimal-change nephropathy. Nephron (1980) 0.93
Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome. J Am Soc Nephrol (1992) 0.93
High-dose methylprednisolone pulses in active lupus nephritis. Lancet (1977) 0.93
Hemolytic uremic syndrome in adults. Arch Intern Med (1980) 0.93
The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation (1990) 0.93
Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol (1994) 0.93
Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years. Lupus (2013) 0.93
Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run. Scand J Clin Lab Invest (2008) 0.92
Renal transplantation in lupus nephritis. Lupus (2005) 0.92
Lipid abnormalities in maintenance dialysis patients and renal transplant recipients. Kidney Int Suppl (1978) 0.92
Role of the kidney in 'salt and water dependent hypertension' of end-stage disease. Clin Sci (1972) 0.92
Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group. Clin Nephrol (1987) 0.92
Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents (2013) 0.91
Peritoneal dialysis in nondiabetic patients older than 70 years: comparison with patients aged 40 to 60 years. Am J Kidney Dis (1998) 0.91
T cell subset alterations in idiopathic glomerulonephritis. Clin Exp Immunol (1982) 0.91
Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy. Clin Nephrol (1992) 0.90
Comparison of immunofluorescent findings in kidney after snap-freezing and formalin fixation. Pathol Res Pract (1989) 0.90
Glomerular disease and pregnancy. A study of 123 pregnancies in patients with primary and secondary glomerular diseases. Nephron (1984) 0.90
Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant (1996) 0.90
Porokeratosis and immunosuppression. Br J Dermatol (1995) 0.90